ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

Biotechnology company ALLOX raised 10.5 million dollars in seed financing led by Asabys to scale its drug discovery platform. The funds support expanding capabilities and developing proprietary AI models to identify therapeutic opportunities from biophysical datasets.
Tap to vote and see what everyone thinks.
Summary by ByteBrief